Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MicroVascular Tissues
AddedFeb 15, 2024
UpdatedJun 18, 2026
MicroVascular Tissues

MicroVascular Tissues

San Diego-based MicroVascular Tissues develops and implants biological vascular tissues since 2014.

HQ
San Diego, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

MicroVascular Tissues, founded in 2014 as a management-led spin-out from Tornier Inc., is based in San Diego, California. The company focuses on developing biological vascular tissues for implantation, aiming to address microvascular deficiencies. Their core mission is to enhance healing potential by increasing blood flow and providing the foundation for tissue repair through their innovative mVASC microvascular tissue solutions. These products are designed to repair, reconstruct, and replace damaged microvascular tissues, thereby improving patient outcomes in various medical conditions.

Notable affiliated individuals and investors include key figures from the biomedical and venture capital sectors, although specific names are not disclosed. Since its inception, MicroVascular Tissues has made significant strides in the field of regenerative medicine, contributing to advancements in tissue engineering and vascular health. Their impact is reflected in the improved healing processes and quality of life for patients with microvascular deficiencies.

MicroVascular Tissues - Similar Companies

Traverse Vascular logo

Traverse Vascular

Cross Vascular logo

Cross Vascular

Vascular Therapies logo

Vascular Therapies

vasculartx.com

Micro Interventional Devices logo

Micro Interventional Devices

Microvascular Therapeutics logo

Microvascular Therapeutics

mvtpharma.com

Attwill Vascular Technologies logo

Attwill Vascular Technologies

TheraVasc logo

TheraVasc

Clear Vascular logo

Clear Vascular

Exogenesis logo

Exogenesis

Vascugen logo

Vascugen

vascugen.com

Regenemed logo

Regenemed

regenemed.com

Micron Biomedical logo

Micron Biomedical

Neograft Technologies logo

Neograft Technologies

Scientia Vascular logo

Scientia Vascular

Vascular Pharmaceuticals logo

Vascular Pharmaceuticals

MicroVascular Tissues - Quick Facts

Who are MicroVascular Tissues' competitors?

Companies similar to MicroVascular Tissues include Traverse Vascular, Cross Vascular, Vascular Therapies and Micro Interventional Devices.

When was MicroVascular Tissues founded?

MicroVascular Tissues was founded in 2014.

Where is MicroVascular Tissues' headquarters located?

MicroVascular Tissues' headquarters is located in San Diego, CA, US.

When was MicroVascular Tissues' last funding round?

MicroVascular Tissues' most recent funding round was for $4.1M (USD) in March 2023.

How much has MicroVascular Tissues raised to-date?

As of Mar 10, 2023, MicroVascular Tissues has raised a total of $9.6M (USD).

How many employees does MicroVascular Tissues have?

MicroVascular Tissues has 30 employees as of Feb 4, 2024.

MicroVascular Tissues - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified